International Vaccination & Capacity Workshop 2019 - Outcomes

Call to Action

The International Vaccination & Capacity Workshop hosted on May 22nd at Campus Biotech in Geneva, Switzerland was enormously successful registering 300+ public health professionals, doctors, diplomats, professors and students from each continent around the world. This was in addition to the 25,131 reaches via our Facebook livestream of the workshop event and 84 shares for participants who were not able to attend.
The workshop was full of robust and stimulating discussions between the audience (both in person and online) and our 20 high-level eloquent speakers from various health sectors around the world.

Highlights from the event

Professor Laetitia Rispel opened the workshop, Dr Marta Lomazzi spoke on the inspiration and idea of the workshop, explaing that the “WFPHA works towards increasing global public health and strongly believes the need to work intersectorally… this workshop was developed as a platform for debate to challenge, listen, and learn from each other”.
These interactions offered a strong interdisciplinary insight into the challenges and potential solutions around vaccinations and capacity. These speakers discussed strategies and good practices to increase primary prevention through increased capacity (from human to infrastructures to sustainable investments and beyond) applied to the vaccination context.
DG Malebona Matsoso explained that “immunization is the most precious gift that healthcare worker can give to a child.. when you immunize children, women, men, and the elderly, we give people an opportunity to live… it remains most cost effective public health intervention".
Vaccinations are one of the World Health Organization's (WHO) top priorities. During this year's World Health Assembly, WFPHA's call to action aims to direct all actors to use an upstream approach as outlined in the Global Charter for the Public's Health. Effective health services are essential to facilitate ongoing prevention, protection, and health promotion strategies. “A truly all-society approach is needed or the situation will get even worse... the lesson learned from the Ebola crisis in 2015 was that integrating the prevention of an epidemic into a health system that are built into community engagement and to trust is key", explains Dr Rüdiger Krech, the Director for Universal Health Coverage and Health Systems at the WHO. The WFPHA recognises the dangers of increasing measles and other outbreaks and that the suboptimal resources for health are not only limited to HRH but also embrace infrastructures, institutional capacity, and strategic investment.
Professor Walter Ricciardi did not need to be present in person to deliver an incredible message. Through his video he explained that his commitment remains despite backlash and attacks of antivax and politicians.

IMG 5099IMG 5099

Dr Svetlana Stefanet from UNICEF commented that “immunization is the biggest return on investment" as she proposesd a number of ways forward to increase vaccination rates through advocacy, the strengthening health and community systems and positioning immunization as a driver for equitable delivery of integrated multi-sectoral interventions.

IMG 5101IMG 5101

Mrs Anuradha Gupta from GAVI stressed that immunisations have reduced child mortality by 60% and unfortunately where a child is born may dictate however whether or not they have access to life-saving vaccines.
Professor Bettina Borisch closed the workshop by gently explaining “we have this word trust… public health systems need to be part of society, and the people, we learn that it has to be with the people”.

Some quotes

Some quotes and important not-to-miss information that will bring you back to the event, in addition to the event livestream on our WFPHA facebook page and live tweets found with #VCW2019, #VaccinesWork, #GlobalCharter.

We need tailored strategies for dealing with vaccine hesitancy." -Professor Jon Wardle

IMG 5013IMG 5013

"Engaging with vaccination companies to avoid conflict of interest requires establishing, reviewing and respecting the organization's protocols." -Professor Michael Moore
"[We must] improve vaccine safety through research and development to win hearts and minds, clarity and consistency needed for country vaccine schedules, and invest into users’ experience to improve the experiences of finding info on vaccines." -Dr Stefan Buttigieg

IMG 5104IMG 5104

"To reach the highest rate of immunizations we need multisector improve population and community health." -Dr Viviana Martinez-Bianchi
"We can’t have universal health coverage without access to vaccination." -Dr Bruce Gelli

Call to Action

The WFPHA released a Call to Action at the end of the workshop for international action to improve the uptake of vaccination internationally and increase professionals’ capacity within and beyond this context. This call has been signed by over 20 health organizations worldwide. The Call to Action aims to direct all actors to appropriately apply the values and strategies outlined in the Global Charter for the Public's Health. This can be done through best practice that improves existing health services and enablers for a resilient health system.

New Diplomats of the Global Charter

Congratulations to DG Malebona Matsoso!

During the opening of the workshop, WFPHA President Laetitia Rispel awarded DG Malebona Precious Matsoso as a Diplomat of the Global Charter for the Public's Health to recognize her efforts to spearhead improvements for public health in South Africa. DG Matsoso is the Director General of the National Department of Health in South Africa, appointed by the President of South Africa on 08 June 2010. She manages health issues for the entire country, as well as reporting to and advising the Health Ministry.


DG Matsoso holds a degree in Pharmacy from the University of Western Cape, a Postgraduate Diploma in Health Management from the University of Cape Town, and a Masters degree in Law and Ethics from the University of Dundee. As a pharmacist she has worked in both the public and private sector at management level. She was a Director in Public Health, Innovation and Intellectual Property in the office of the Director General of the World Health Organisation. Her career within the field of medicine control has included posts as Head of Medicines Control Council for seven years overseeing 10 technical committees, member of the National Research Ethics Council of South Africa, and Director of the Essential Drugs and Traditional Medicines Programme. She has also been a member of various advisory panels with an emphasis on improving access to medicines and anti-retrovirals. The WFPHA is pleased to welcome DG Matsoso as a Diplomat of the Global Charter.

This new Diplomat has joined other 31 committed public health leaders in implementing the Global Charter for the Public Health.

The WFPHA calls upon health organization to continue join the development of the Global Charter of Public Health to fully embrace and promote its services of protection, prevention and health promotion as well as its four enabler functions of good governance, accurate information, effective advocacy and capacity building. Utilization of these services and functions will serve as a pathway to resilient health systems globally.

BECOME A DIPLOMAT OF THE GLOBAL CHARTER NOW and sustain this global public health revolution!" For more info, connect here:


For the program: please click here

Speakers' biographies

Professor Bettina Borisch, WFPHA Executive Director and Professor of Global Health, University of Geneva, Switzerland

Prof. Borisch is an MD and a Histopathologist, MPH and Fellow of the Royal College of Pathology (UK). Her scientific research work delves into neoplastic lesions of the immune system and breast cancer. Her interests also include community-based oncology, as well as health communication and global health. She is the Editor in Chief of “Pathobiology” and the Co-Editor of “Journal of Public Health Policy”. In addition to her academic work, she is the Director of the World Federation of Public Health Associations and has held positions at several Committees of Public Health oriented institutions. She was president of Europa Donna – The European Breast Cancer Forum – and Founding President of the Swiss Forum of Europa Donna. She teaches at the University of Geneva, the Swiss School of Public Health and she also teaches patient support groups. She is the author of over 120 scientific papers and 2 books.

Dr. Stefan Buttigieg, Specialist Trainee at the Ministry of Health, Malta and Co-Chair WFPHA Digital Health WG

Dr. Buttigieg is a Higher Specialist Trainee in Public Health Medicine at the Ministry of Health in Malta. He’s also the Co-Chair of the WFPHA Working Group on Global Health Equities and Digital Technologies and co-Founder of Digital Health Malta, a non-governmental organization focused on developing a Digital Health Community in Malta. He is an Author, Tutor and Digital Health Consultant focused on creating transformative and effective change. Dr. Buttigieg graduated from the University of Malta as a Doctor of Medicine and Surgery and holds a Masters of Science in Public Health. Furthermore, he graduated with a Masters of Health Informatics from the University of Sheffield in 2018. Dr. Buttigieg’s research interests focus on Social Media, Digital Health and Public Health Informatics. He is passionate about establishing contacts with people from all walks of life, energizing him to get the best out of people and helping them achieve their technological goals and vision.

Mr. Chris Colwell, Executive Director of International Vaccine Public Policy, MSD

Chris Colwell is the Executive Director of International Vaccine Public Policy at Merck & Co. He is a leader in global public affairs and government affairs, first receiving his Masters Degree in Public Policy at Georgetown University. He has 20 years of experience in healthcare, including engineering, operations management, policy development, communications and global advocacy initiatives. This experience includes working as a Policy Advisor at the FDA, Director of Healthcare Regulatory Affairs at BIO, and Director of Worldwide Public Policy and Senior Director of Public Affairs for Greater Asia at BD. Chris works to build and strengthen organizational capabilities across a range of disciplines and applies his experience to develop and execute advocacy and market access strategies that are aligned with business objectives of governments and other stakeholders. Chris has successfully worked with a broad range of U.S. and international stakeholders and is adept to working within and across many cultural settings.

Mrs. Lois Privor-Dumm, Director of Policy, Advocacy & Communications, IVAC

Lois Privor-Dumm is the Director of Policy, Advocacy & Communications (PAC) at the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health. She leads PAC team efforts on a variety of projects at country, regional, and global level, including advocacy and capacity building in low- and middle- income countries and policy research and advocacy for adult vaccines. She also works on new vaccine introduction support for pneumococcal, rotavirus, and HPV, advice and training on vaccine confidence, and the communication of evidence to establish the broader value of vaccines through IVAC’s VoICE tool. Prior to joining Hopkins, she worked nearly 18 years in the private sector with roles in marketing, finance, and regional operations, most notably launching the pneumococcal conjugate vaccine in the US and supporting other countries in Latin America and Europe. She holds a Masters in International Business Studies from the University of South Carolina.

Dr. Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

Dr. Bruce Gellin, M.D. M.P.H., is the President of Global Immunization at the Sabin Vaccine Institute. Dr. Gellin previously served as the Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Service (HHS), where he was the principal advisor to the Assistant Secretary for Health on vaccine and immunization programs and policies. Dr. Gellin also represented HHS as a technical and policy advisor to the World Health Organization with a focus on influenza and vaccine hesitancy and as a contributor to the Decade of Vaccines Collaboration and the Global Vaccine Action Plan (GVAP). He earned an M.P.H. in Epidemiology from the Columbia University Mailman School of Public Health, is a graduate of Weill Cornell Medical College, and was a Morehead Scholar at the University of North Carolina at Chapel Hill and previously worked at CDC and NIH. Dr. Gellin has achieved board certification in internal medicine and infectious diseases and serves as a peer reviewer for over a dozen medical journals.

Mrs. Anuradha Gupta, Deputy CEO of the GAVI Alliance

Anuradha Gupta is the Deputy Chief Executive Officer of Gavi, the Vaccine Alliance. Prior to joining Gavi, Anuradha served as Secretary at the Indian Ministry of Health and Family Welfare, and Mission Director of the National Health Mission where she ran the largest public health programme in the world with an annual budget of US$ 3.5 billion. Anuradha played a leading role in India’s efforts to eradicate polio transmission. She has also led efforts to pioneer free care for over 165 million pregnant mothers and children, introduce universal health screening for 270 million children, and design an innovative health programme for 350 million adolescents. In addition, Anuradha has been Co-Chair of the Partnership for Maternal, Neonatal and Child Health (PMNCH), member of the Steering Committee of the “Child Survival Call to Action” at the invitation of Secretary of State Clinton, Co-Chair of the Stakeholder Group for the London Family Planning Summit 2020, and member of the Family Planning 2020 Reference Group. Anuradha has a Masters in English Literature from Kurukshetra University, an MBA from the University of Wollongong in Australia, and an Executive Education from Stanford School of Business and Harvard’s Kennedy School of Government.

Dr. Richard Hatchett, Chief Executive Officer, the Coalition for Epidemic Preparedness Innovations (CEPI)

Dr. Richard J. Hatchett, MD, is the Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that will finance and co-ordinate the development of vaccines against high priority public health threats and vaccine platform technologies to respond rapidly to emerging infectious diseases with pandemic or epidemic potential. Dr. Hatchett most recently served as acting Director of the U.S. Biomedical Advanced Research and Development Authority (BARDA), after serving for five years as BARDA’s Chief Medical Officer and Deputy Director. At BARDA, Dr. Hatchett oversaw programs to develop medical countermeasures against chemical, biological, radiological and nuclear threats, pandemic influenza, and emerging infectious diseases and led or helped lead the development of vaccines, therapeutics, and diagnostics for a number of emerging viruses. Dr. Hatchett has served on the White House Homeland Security Council under President George W. Bush and was a member of the White House National Security Staff under President Barack Obama. He is a recipient of the HHS Secretary’s Award for Distinguished Service and a five-time recipient of the NIH Director’s Merit Award. A graduate of Vanderbilt University, he completed a residency in internal medicine at the New York Hospital – Cornell Medical Center and a fellowship in medical oncology at Duke University Medical Center.  

Professor Samia Hurst, Director of the Institute for Ethics, History and the Humanities and CIOMS Vice-president

Prof. Samia Hurst is a bioethicist and doctor, consultant of the Clinical Ethics Council of Geneva University Hospitals (HUG), head of the Clinical Ethics Unit of the CHUV, and director of the Institute Ethics, History, and Humanities (IEH2) at the Faculty of Medicine of Geneva. Former President of the Swiss Society for Biomedical Ethics, she published the journal Bioethica Forum. She is also Vice-Chair of the CIOMS Executive Committee, and a member of the Swiss Personalized Health Network's Ethical Legal Social Issues Advisory Group, the National Commission of Ethics in the Field of Human Medicine and the Senate of the United States Swiss Academy of Medical Sciences. In the past, she was a post-doctoral fellow at the Bioethics Department of the National Institutes of Health (NIH) in Bethesda. She was a founding member of the European Clinical Ethics Network, and co-organized the Brocher Summer Academies in the Ethics of Global Population Health with Harvard University. Her research focuses on the ethical issues of clinical practice, research, and health policy, particularly issues of equity and protection of vulnerable people.

Dr. Rüdiger Krech, Director, Health Systems and Innovation, Office of the Assistant Director-General, WHO

Rüdiger Krech is the Director for Universal Health Coverage and Health Systems at the World Health Organization. The cluster of Universal Health Coverage (UHC) covers the WHO’s work in the areas of integrated people-centered health services, health workforce, financing and health governance. As his role is located in the Assistant Director-General’s Office, he acts on behalf of, and represents her in meetings, committees and other events and facilitates coordination and coherence between the health systems work of the Organization and other areas of public health. He is the cluster’s focal point for the WHO transformation, in particular on issues relating to WHO leadership priorities, governance and management. Before that, Dr. Krech was the Director of the Department of Ethics, Equity, Trade and Human Rights at the World Health Organization from 2009 to 2012. In this role, he was also responsible for WHO’s work on Social Determinants of Health and Health in All Policies.

Dr. Irina Ljungqvist, Senior Expert Pubic Health Capacity, ECDC

Dr. Irina Ljungqvist is a Senior Expert Pubic Health Capacity at the European Centre for Disease Prevention and Control (ECDC) in Sweden. She is a public health physician with a PhD in Public Health with more than 25 years experience in health communication, health policy, and public health. Her current projects include workforce capacity strengthening for EU Member States in communicable disease prevention and control, focusing on increasing vaccine acceptance through training healthcare professionals, capacity strengthening in infection prevention and control and hospital acquired infections. She has also worked on bridging evidence with policy and practice and core competencies for field epidemiologists and microbiologists. In the past, Dr. Ljungqvist has worked for John Snow, Inc. on a large-scale program on sexual and reproductive health in Romania and Eastern Europe being responsible for policy and behavior change areas, coordinating health promotion activities in Romania, and has set up an NGO focusing on delivering sexual and reproductive health education for young people using peer education in Romania - "Youth for Youth Foundation".

Dr. Marta Lomazzi, WFPHA Executive Manager and Lecturer, University of Geneva, Switzerland

Marta Lomazzi is a Medical Biotechnologist with a PhD in Neuroscience and over 15 years’ experience in public health and nutrition. After few years dedicated to basic research focusing on the mechanisms of addiction to drugs of abuse, she joined the Institute of Global Health where she works as Lecturer and Researcher. Since 2009 she works as consultant for the evaluation of public health activities in different areas. In 2011, she joined the World Federation of Public Health Associations (WFPHA) where she works as Executive Manager. Her main duties are the elaboration and management of public health programs, partnerships development, as well as fundraising for the official representation of WFPHA within WHO. She teaches at the University of Geneva, is the Co-Editor of “Journal of Public Health Policy” and is the author of several publications in the public health field.

Dr. Viviana Martinez-Bianchi, WHO Liaison - World Organization of Family Doctors (WONCA), and Program Director Duke Family Medicine Residency Program, Duke Department of Family Medicine and Community Health

Dr. Viviana Martinez-Bianchi, MD, FAAFP is a member of the executive board of the World Organization of Family Doctors (WONCA) and Liaison to the World Health Organization. She is the Program Director of the Family Medicine Residency Program, at Duke University's Department of Family Medicine and Community Health in Durham, North Carolina, USA. She is chair of the Health Equity Team for Family Medicine for America's Health, and the Organizational Equity Committee of WONCA.  Her work addresses family doctors’ clinical education, teamwork, and interprofessional education. As a clinician she practices family medicine, caring for the whole family, from prenatal care to end of life, prevention, chronic disease management, community health, addressing social determinants of health and improving health equity. 

Ms. Malebona Precious Matsoso, Director-General, Department of Health, South Africa

Mrs. Malebona Precious Matsoso is the Director General of the National Department of Health in South Africa, appointed by the President of South Africa on 08 June 2010. She manages health issues for the entire country, as well as reporting to and advising the Health Ministry. Mrs. Matsoso holds a degree in Pharmacy from the University of Western Cape, a Postgraduate Diploma in Health Management from the University of Cape Town, and a Masters degree in Law and Ethics (LLM) from the University of Dundee. As a pharmacist she has worked in both the public and private sector at management level. Mrs. Matsoso has experience serving as the Registrar of Medicines of the National Drug Regulatory Authority in South Africa and as Secretariat of the Southern African Development Community (SADC). Ms. Matsoso was a Director in Public Health, Innovation and Intellectual Property (PHI) in the office of the Director General of the World Health Organisation (WHO). Her career within the field of medicine control has included posts as Head of Medicines Control Council (MCC) for seven years overseeing 10 technical committees, member of the National Research Ethics Council of South Africa, and Director of the Essential Drugs and Traditional Medicines Programme. She has also been a member of various advisory panels with an emphasis on improving access to medicines and anti-retrovirals.

Mr. Michael Moore, WFPHA Immediate Past President and Distinguished Fellow, The George Institute of Global Health

Michael Moore is the chair of a number of health networks. He is a former Minister of Health and Community Care and was an Independent member of the Australian Capital Territory Legislative Assembly for four terms from 1989 to 2001. He was Australia’s first independent Minister when he was appointed as Minister of Health and Community Care. Moore is a former teacher, small business owner and consultant who holds a post-graduate diploma in education, a master’s degree in population health from the ANU, is a Visiting Professor at the University of Technology Sydney, and an adjunct professor with the University of Canberra where he is a PhD Scholar examining a framework for planning or evaluating health advocacy. He is widely published. He is also a political and social columnist who has served on a range of academic and community Boards. Michael Moore also is the immediate past President of the World Federation of Public Health Associations. 

Professor Walter Ricciardi, WFPHA President-elect and Professor of Hygiene and Public Health, Catholic University of the Sacred Heart, Rome, Italy

Walter Ricciardi is Professor of Hygiene and Public Health at the Catholic University of the Sacred Heart in Rome. In August 2015 Walter Ricciardi was appointed President of the Italian National Institute of Health (Istituto Superiore di Sanità) where he was Commissioner from 2015 to 2018. In 2003 he was appointed President of the European Public Health Association (EUPHA), in 2010 he was elected President again and in 2011 he was re-elected for a second term up to 2014. Since 2014 he is Past President of EUPHA. In December 2015, he was appointed Director of the WHO Collaborating Centre for Health Policy, Governance and Leadership at the Institute of Public Health, Medical School, and Catholic University of the Sacred Heart – Rome. In November 2017 he was appointed Member of the Executive Board of the World Health Organization.

Professor Laetitia Rispel, WFPHA President and Professor of Public Health, University of the Witwatersrand, Johannesburg, South Africa

Laetitia Rispel has extensive and wide-ranging experience of research, teaching, and health leadership in different settings, and has published extensively on different aspects of health policy and the transformation of the South African health system. She has won several national and international awards, including the South African Shoprite/Checkers/SABC2 woman of the year award in the health category (2003); International Nurse Researcher Hall of Fame of the Sigma Theta Tau Nursing Honors Society (2013); Gauteng branch of the South African Medical Association award in the allied category (2013); University vice-chancellor’s academic citizenship award (2014); Academy of Science of South Africa membership award (2015). Since 2018, she is the President of the World Federation of Public Health Associations, the first African woman in the 50-year history of the organisation to achieve this honour. 

Dr. Svetlana Stefanet, Regional Immunization Specialist, UNICEF

Svetlana Stefanet is the current Regional Immunization Specialist at UNICEF Regional Office for Europe and Central Asia. Prior to this, Dr. Stefanet served as the Chief of Health Programs at UNICEF Uzbekistan from 2012 to 2017, implementing and managing the overall health component of the country programme, which included MCH, nutrition, HIV/AIDS, and WASH projects. She provided leadership and guidance to key government and non-government partners on national policies, strategies, and programs. From 2006 to 2012, Dr. Stefanet served as Chief Health and Education at UNICEF Moldova, designing and implementing basic educational interventions for Moldova. Dr. Stefanet has also worked as an Associate Professor and Senior Lecturer at the State Medical and Pharmaceutical University in Moldova.

Mr. Adrian Te Patu, Co-Chair WFPHA Indigenous WG & Strategic Advisor, Hapai Te Hauora, New Zealand

Adrian Te Patu is an active member of the Governing Council at WFPHA where he represents New Zealand and the Asia-Pacific region. He is the first indigenous member of the council. For over three decades, Mr. Te Patu has worked for government departments, crown agencies, community organizations, Iwi, District Health Board's and other health providers. He has also been a member of various government reference groups and has had numerous board and governance roles. In more recent years, Mr. Te Patu has worked as a tutor, trainer and advisor in public health, health promotion and indigenous health. He is a Maori Caucus member and Co-Vice President of the Public Health Association of New Zealand. In addition, Mr. Te Patu served on the board of the Health Promotion Forum of New Zealand and served two terms as an elected member of the Christchurch City Council on the Lyttelton Mt. Herbert Community Board.

Dr. Samantha Vanderslott, Social Sciences Researcher, University of Oxford, UK

Dr. Samantha Vanderslott is a social sciences researcher at the University of Oxford working on health, society, and policy topics. She completed her PhD in the STS Department on the policy development for 'Neglected Tropical Diseases' at the University College London in 2017, after working as a senior policy advisor in the UK Civil Service. In 2016, Dr. Vanderslott joined the Oxford Vaccine Group as a Social Science Researcher as part of the Oxford Martin School Programme "The Human Factor: Infectious Disease and Collective Responsibility". She is also a Junior Researcher Fellow at Linacre College. With a background in global governance, international development, and scientific studies, Dr. Vanderslott draws on perspectives from sociology, history, global public health, and science and technology studies. In addition to her academic and research work, she has published in journals including "Social Science and Medicine", "Infectious Diseases of Poverty", and "Human Development and Capabilities". Her current projects focus on attitudes to vaccination, policies for neglected tropical diseases, past and present challenges of typhoid, and health research during outbreaks. 

Assistant Professor Jon Wardle, Head of Regulatory, Policy, and Legislative Stream, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney

Jon Wardle is an Associate Professor of Public Health at the University of Technology Sydney and heads the Regulatory, Legislative and Policy Stream at the Australian Research Centre in Complementary and Integrative Medicine, where he holds a prestigious National Health and Medical Research Council Research Translation Fellowship aimed at increasing vaccines. In addition to his clinical qualifications in nursing and naturopathy, Jon has postgraduate qualifications in public health, law and health economics and holds visiting positions at the Schools of Medicine at University of Washington and Boston University. Jon has published more than 120 peer-reviewed journal articles, 20 academic book chapters and 4 academic books, and serves on the editorial board of 8 international academic journals. Jon is co-convener of the Public Health Association of Australia’s Complementary Medicine Special Interest Group, is part of the executive of the American Public Health Association Integrative Health Section Policy Committee and has been an advisor on this issue to the WHO. Jon is actively involved in the PHAA Research Advisory Group and Parliamentary hearings on topics such as food and nutrition, practitioner regulation and health law. Jon has worked on traditional medicine, public health and primary health care policy and regulatory initiatives with numerous governments, non-government organizations and international bodies

Sponsorship and Exhibitors

Sponsors and Supporters

Thank you to our sponsors!

Screen Shot 2019 06 17 at 4.02.47 PMScreen Shot 2019 06 17 at 4.02.47 PM

Platinum Sponsor Profile



Thank you to our exhibitors!

Screen Shot 2019 06 17 at 4.06.20 PMScreen Shot 2019 06 17 at 4.06.20 PM




Campus Biotech

9 Chemin des Mines

1202 Geneva


Key contacts

  • Marta Lomazzi, PhD 
    Executive Manager 
    World Federation of Public Health Associations 
    Tel: +41 22 3790455 
  • Eleonora De Cata, PhD
    Office Manager
    World Federation of Public Health Associations
    Tel: +41 22 3790484
Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInShere with friendsDisplay print-friendly version